Luyan Pharma Co.,Ltd. (SHE:002788)

Market Cap	6.10B +93.9%
Revenue (ttm)	20.91B +2.1%
Net Income	307.96M -14.2%
EPS	0.80 -14.0%
Shares Out	388.52M
PE Ratio	19.61
Forward PE	n/a
Dividend	0.35 (2.25%)
Ex-Dividend Date	Jul 10, 2025

Volume	14,670,217
Average Volume	35,015,666
Open	15.52
Previous Close	15.59
Day's Range	15.47 - 15.76
52-Week Range	7.23 - 28.29
Beta	0.39
RSI	41.40
Earnings Date	Apr 21, 2026

About Luyan Pharma

Luyan Pharma Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical products in China. The company distributes medicines, Chinese herbal medicines, medical devices, and others; and provides medical care, elderly care, and wellness services. It also operates pharmaceutical retail chains. The company was formerly known as Luyan (Fujian) Pharma Co. Ltd. and changed its name to Luyan Pharma Co.,Ltd. in June 2016. Luyan Pharma Co.,Ltd. was founded in 1992 and is headquartered in Xiamen,...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 1992
• Employees: 5,602
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002788

Financial Performance

In 2024, Luyan Pharma's revenue was 20.47 billion, an increase of 3.15% compared to the previous year's 19.85 billion. Earnings were 345.64 million, a decrease of -4.92%.